Novartis targets Turkey for plant, other expansion; Piramal gets grant for ADC plant in Scotland;

> Novartis ($NVS) director Alexandre F. Jetzer Chung reportedly said that company is planning a new manufacturing plant in Turkey and sees that country as potentially replacing Egypt as the center of healthcare for North Africa. Item

> A £145,000 grant from Scottish Enterprise was given to Piramal Healthcare to entice the Indian company to open manufacturing operations in Grangemouth, Scotland, where it will make antibody-drug conjugates (ADC). Story

> The Medicines and Healthcare Products Regulatory Agency has posted a warning for U.K. surgeons to stop using a specific combination of metal hip products from Stryker Corp. ($SYK) and Johnson & Johnson ($J&J) because of the "unacceptably high" failure rates. Article

> Cleveland-based Research Organics has been acquired by Sigma Aldrich to expand its capacity of buffer production and increase its pharmaceutical-grade raw material lines. Story

> Gerresheimer Medical Plastic Systems has added a pharmaceutical packaging assembly area with 3 clean rooms to its facility in Regensburg Germany. News

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.